QC
CRL icon

Quent Capital’s Charles River Laboratories CRL Stock Holding History

Quent Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Hold
127
– – ﹤0.01% 968
2026
Q1 		$21.9K Sell
127
-6
-5% -$1.11K ﹤0.01% 967
2025
Q4 		$26.5K Sell
133
-12
-8% -$2.18K ﹤0.01% 920
2025
Q3 		$22.7K Buy
+145
New +$23K ﹤0.01% 821
2025
Q2 		– Sell
-160
Closed -$24.1K – 486
2025
Q1 		$24.1K Buy
160
+4
+3% +$671 ﹤0.01% 726
2024
Q4 		$28.8K Hold
156
– – ﹤0.01% 718
2024
Q3 		$30.7K Hold
156
– – ﹤0.01% 782
2024
Q2 		$32.2K Sell
156
-24
-13% -$5.44K ﹤0.01% 742
2024
Q1 		$48.8K Buy
180
+1
+0.6% +$239 0.01% 671
2023
Q4 		$42.3K Sell
179
-12
-6% -$2.36K 0.01% 660
2023
Q3 		$37.4K Sell
191
-13
-6% -$2.67K 0.01% 659
2023
Q2 		$42.9K Hold
204
– – 0.01% 626
2023
Q1 		$41.2K Buy
204
+6
+3% +$1.36K 0.01% 638
2022
Q4 		$43.1K Hold
198
– – 0.01% 620
2022
Q3 		$39K Buy
198
+44
+29% +$9.5K 0.01% 608
2022
Q2 		$33K Hold
154
– – 0.01% 616
2022
Q1 		$44K Buy
154
+38
+33% +$11.7K 0.01% 630
2021
Q4 		$44K Buy
+116
New +$45.1K 0.01% 580

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Quent Capital's CRL Position: Q2 2026 in Review

Quent Capital held its Charles River Laboratories (CRL) position steady in Q2 2026 at 127 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Quent Capital first reported a position in CRL in Q4 2021 and has held it in 18 quarters since. The position peaked at $48.8K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Quent Capital held 127 shares of Charles River Laboratories worth $28.8K as of Q2 2026.
  • Quent Capital left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #968 holding.
  • Quent Capital first reported a position in Charles River Laboratories in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Charles River Laboratories position peaked at $48.8K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.